Logo image of ESGC

EROS STX GLOBAL CORP (ESGC) Stock Fundamental Analysis

NYSE:ESGC - IM00BMT7S123 - Common Stock

3.03
+0.55 (+22.18%)
Last: 6/3/2022, 8:17:40 PM
2.88
-0.15 (-4.95%)
After Hours: 6/3/2022, 8:17:40 PM
Fundamental Rating

1

ESGC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 75 industry peers in the Entertainment industry. ESGC may be in some trouble as it scores bad on both profitability and health. ESGC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ESGC was profitable.
ESGC Yearly Net Income VS EBIT VS OCF VS FCFESGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA -37.44%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESGC Yearly ROA, ROE, ROICESGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -45.47%
PM (TTM) -269.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ESGC Yearly Profit, Operating, Gross MarginsESGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ESGC has more shares outstanding
Compared to 1 year ago, ESGC has a worse debt to assets ratio.
ESGC Yearly Shares OutstandingESGC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M
ESGC Yearly Total Debt VS Total AssetsESGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 500M 1B

2.2 Solvency

Based on the Altman-Z score of -2.49, we must say that ESGC is in the distress zone and has some risk of bankruptcy.
ESGC has a Debt/Equity ratio of 0.71. This is a neutral value indicating ESGC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -2.49
ROIC/WACCN/A
WACCN/A
ESGC Yearly LT Debt VS Equity VS FCFESGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.52 indicates that ESGC may have some problems paying its short term obligations.
A Quick Ratio of 0.52 indicates that ESGC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
ESGC Yearly Current Assets VS Current LiabilitesESGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 185.97% over the past year.
The Earnings Per Share has been growing by 32.11% on average over the past years. This is a very strong growth
ESGC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.43%.
Measured over the past years, ESGC shows a very negative growth in Revenue. The Revenue has been decreasing by -11.36% on average per year.
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%

3.2 Future

The Earnings Per Share is expected to decrease by -34.09% on average over the next years. This is quite bad
ESGC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 69.34% yearly.
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESGC Yearly Revenue VS EstimatesESGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ESGC Yearly EPS VS EstimatesESGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.53 indicates a rather cheap valuation of ESGC.
Compared to an average S&P500 Price/Earnings ratio of 27.08, ESGC is valued rather cheaply.
ESGC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 1.53
Fwd PE N/A
ESGC Price Earnings VS Forward Price EarningsESGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -133.2
ESGC Per share dataESGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as ESGC's earnings are expected to decrease with -67.73% in the coming years.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%

0

5. Dividend

5.1 Amount

ESGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EROS STX GLOBAL CORP

NYSE:ESGC (6/3/2022, 8:17:40 PM)

After market: 2.88 -0.15 (-4.95%)

3.03

+0.55 (+22.18%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)01-14 2022-01-14/bmo
Earnings (Next)06-17 2022-06-17/bmo
Inst Owners59.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.42M
Analysts82.86
Price Target3.57 (17.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.53
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB N/A
EV/EBITDA -133.2
EPS(TTM)1.98
EY65.35%
EPS(NY)-4.14
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.21
BVpS21.24
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA -37.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -45.47%
PM (TTM) -269.45%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -2.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A